Skip to main content
. Author manuscript; available in PMC: 2018 Nov 5.
Published in final edited form as: J Invest Dermatol. 2017 Apr 24;137(8):1663–1670. doi: 10.1016/j.jid.2017.04.008

Figure 2. CXCL9 is increased in inflammatory morphea skin.

Figure 2.

(a) CXCL9 mRNA expression is increased in lesional skin compared with site-matched unaffected skin. (b, c) CXCL9 is present in dermal interstitial infiltrates and stains dendritic-appearing cells. Arrows indicate typical perinuclear cap staining pattern of CXCL9. Scale bar in b = 100 mm; scale bar in c = 25 mm.